International - Drug - Development - Biotech
Records under this name other than the patents International - Drug - Development - Biotech holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 7 of 7 · Back to International - Drug - Development - Biotech
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,611,327 | ANTI-DR5 Family Antibodies, Bispecific or Multivalent ANTI-DR5 Family Antibodies and Methods of Use Thereof now held by Genmab B.V. In force · High confidence | In force | High confidence | |
| US RE49,192 | ANTI-CD19 Antibody Having Adcc and CDC Functions and Improved Glycosylation Profile Lapsed on the fee record Ended May 30, 2025 · Low confidence | Lapsed on the fee record | Ended May 30, 2025 | Low confidence |
| US 9,663,583 | ANTI-CD19 Antibody Having Adcc and CDC Functions and Improved Glycosylation Profile Surrendered on reissue Surrendered on reissue Aug 30, 2022 · Low confidence | Surrendered on reissue | Surrendered on reissue Aug 30, 2022 | Low confidence |
| 13/811,134 | Method to Improve Glycosylation Profile and to Induce Maximal Cytotoxicity for Antibody Abandoned Abandoned Oct 31, 2016 | Abandoned | Abandoned Oct 31, 2016 | |
| 16/639,441 | Treatment of CK8 Positive Cancers in Relation with K-Ras Gene Status Abandoned Abandoned Nov 30, 2022 | Abandoned | Abandoned Nov 30, 2022 | |
| 17/777,458 | ANTI-CD117 Antibodies and Methods of Use Thereof Abandoned Abandoned Jan 3, 2026 | Abandoned | Abandoned Jan 3, 2026 | |
| 17/955,880 | Treatment of CK8 Positive Cancers in Relation with K-Ras Gene Status Abandoned Abandoned Oct 2, 2024 | Abandoned | Abandoned Oct 2, 2024 |